GlaxoSmithKline plc (ADR) (NYSE:GSK)

CAPS Rating: 4 out of 5

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Recs

2
Player Avatar BinyaminK (71.97) Submitted: 11/9/2011 1:47:16 PM : Outperform Start Price: $42.21 GSK Score: -1.51

This is a "Giant Tortoise Stock." Like a giant tortoise, It may be big and slow, but it has a hard shell (economic moat), can swim far (enter into new and emerging markets and industries), and live long.

Featured Broker Partners


Advertisement